Tech Optimist Episode 24: This Startup Is Making Your Daily Products Safer

Ruby Bio uses a revolutionary platform to transform sugar into high-performance chemicals used in everyday products

2 min readJul 9, 2024

Tech Optimist, presented by Alumni Ventures, focuses on the intersection of technology, entrepreneurship, and innovation. We are passionate about technology and its potential to drive positive change. We explore our lane through with founders, investors, and futurists; discussions of new innovations; and reviews of trends in technology and venture capital. Subscribe Here »

In this episode, Alumni Ventures Managing Partner Greg Baker chats with Charlie Silver, Co-Founder and CEO of Ruby Bio.

Charlie shares how his company is redefining the chemical industry by replacing harmful petrochemicals with more sustainable alternatives. Ruby Bio uses a revolutionary platform to transform sugar into high-performance chemicals used in everyday products like detergents and shampoos. These innovations not only aim to enhance product quality but also significantly reduce environmental impact. Tune in to learn how Ruby Bio is paving the way for a cleaner, safer future, tackling some of the largest markets in the world with their sustainable solutions.

Alumni Ventures offers accredited individuals access to professional-grade venture capital, a key asset class missing from the portfolios of many sophisticated investors. Since 2014, AV has raised $1.3+ billion from 10,000+ investors and backed 1,300+ unique portfolio companies. AV is a top 20 venture firm in North America according to CB Insights, as well as the #1 most active venture firm in the U.S., and #3 most active in the world, according to PitchBook’s 2022 and 2023 rankings. AV has won awards from Inc. Magazine, Fast Company, Benzinga, and the US FinTech Awards.

--

--

Alumni Ventures
Alumni Ventures

Written by Alumni Ventures

Content at the intersection of venture capital and entrepreneurship, covering innovation in AI, energy, healthtech, law, sports, and more.

No responses yet